# Lipocine Historical Financial Ratios

LPCN | - USA Stock | ## USD 1.13 0.04 3.42% |

Lipocine is lately reporting on over 66 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Accounts Payable Turnover of 0.16 will help investors to properly organize and evaluate Lipocine financial condition quickly. Financial Statement Analysis is infinitely more than just reviewing and investigating Lipocine recent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lipocine is a good buy for the upcoming year.

Additionally, see Stocks Correlation.## Lipocine Historical Statements | Lipocine |

## About Lipocine Financial Ratios Analysis

LipocineFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Lipocine investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Lipocine financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Lipocine history.

## Lipocine Financial Ratios Chart

Lipocine financial ratios usually calculated using numerical values taken directly from Lipocine financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Lipocine. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.

Lipocine Current Ratio is quite stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 3.95. Sales per Share is expected to rise to 0.005542 this year, although the value of Cash Flow Per Share will most likely fall to (0.30) . Add Fundamental

## Asset Turnover

Asset turnover is a measure of a firms operating efficiency; calculated by dividing Revenues by Average Assets. Often a component of DuPont ROE analysis.## Return on Average Assets

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].## Return on Average Equity

Return on equity measures a corporation's profitability by calculating the amount of Net Income Common Stock returned as a percentage of [EquityAvg].## Return on Sales

Return on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont ROE analysis.Most ratios from Lipocine fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Lipocine Current Ratio is quite stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 3.95. Sales per Share is expected to rise to 0.005542 this year, although the value of Cash Flow Per Share will most likely fall to (0.30) .

2010 | 2019 | 2020 | 2021 (projected) | |

PPandE Turnover | 9.1 | 14.63 | 13.17 | 11.93 |

Long Term Debt to Equity | 0.73 | 0.61 | 0.7 | 0.76 |

## Lipocine fundamentals Correlations

**Click cells**to compare fundamentals

## Lipocine Account Relationship Matchups

### High Positive Relationship

### High Negative Relationship

## Lipocine fundamentals Accounts

2016 | 2017 | 2018 | 2019 | 2020 | 2021 (projected) | ||

Cash Flow Per Share | (0.99) | (0.79) | (0.56) | (0.31) | (0.28) | (0.3) | |

Total Assets Per Share | 1.48 | 1.19 | 0.96 | 0.52 | 0.6 | 0.62 | |

Quick Ratio | 20.27 | 3.39 | 3.4 | 2.84 | 3.26 | 3.35 | |

Net Current Assets as percentage of Total Assets | 94.66 | 74.53 | 78.25 | 74.61 | 67.14 | 72.44 | |

Book Value per Share | 2.55 | 1.43 | 0.95 | 0.44 | 0.24 | 0.28 | |

Current Ratio | 13.23 | 20.52 | 3.98 | 4.63 | 3.95 | 3.85 | |

Debt to Equity Ratio | 0.051 | 0.33 | 1.21 | 2.13 | 0.65 | 0.63 | |

Earnings per Basic Share | (1.04) | (1.05) | (0.55) | (0.5) | (0.38) | (0.41) | |

Earnings per Diluted Share | (1.04) | (1.05) | (0.55) | (0.5) | (0.38) | (0.41) | |

Earnings per Basic Share USD | (1.04) | (1.05) | (0.55) | (0.5) | (0.38) | (0.41) | |

Enterprise Value over EBIT | (2.0) | (12.0) | (3.0) | (4.0) | (4.6) | (4.96) | |

Enterprise Value over EBITDA | (3.3) | (3.04) | (2.43) | (0.49) | (3.78) | (4.08) | |

Free Cash Flow per Share | (1.0) | (0.83) | (0.57) | (0.45) | (0.28) | (0.3) | |

Price to Book Value | 2.58 | 3.84 | 2.96 | 1.56 | 5.82 | 5.02 | |

Price to Earnings Ratio | (3.54) | (3.28) | (2.36) | (0.77) | (3.58) | (3.86) | |

Return on Average Equity | (0.44) | (0.63) | (0.9) | (1.44) | (1.69) | (1.74) | |

Return on Invested Capital | (0.91) | (1.48) | (0.54) | (1.07) | (4.72) | (5.1) | |

Tangible Assets Book Value per Share | 1.5 | 1.26 | 0.98 | 0.76 | 0.46 | 0.47 |

## Be your own money manager

Our tools can tell you how much better you can do entering a position in Lipocine without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.## Did you try this?

### Run Premium Stories Now

## Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |

All Next | Launch Module |

## Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lipocine using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.## Build Optimal Portfolios

### Align your risk with return expectations

Additionally, see Stocks Correlation. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

## Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go | |

Insider ScreenerFind insiders across different sectors to evaluate their impact on performance | Go | |

Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk | Go | |

Probability Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years | Go | |

Bond DirectoryFind actively traded corporate debentures issued by US companies | Go | |

Technical AnalysisCheck basic technical indicators and analysis based on most latest market data | Go | |

Transaction HistoryView history of all your transactions and understand their impact on performance | Go | |

Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device | Go | |

Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | Go |

The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.